Many factors contributed to the impressive speed with which COVID-19 vaccines were created, produced, and deployed, including novel vaccine modalities and recent advancements in downstream purification tools. These advancements remain powerful in the continued search for vaccines against persistent infectious agents such as HIV and malaria.
This webinar will present improved purification tools developed for rapid candidate screening and intensified downstream processing of various vaccine modalities, including mRNA, viral vector vaccines, and virus-like particles (VLPs). Examples of each vaccine modality and the associated purification tools will be given, including case studies and performance data.
Attend this webinar to learn more about